122 related articles for article (PubMed ID: 2511711)
21. [Effect of acridine compounds on stopping the development of drug resistance in Mycobacterium tuberculosis (an experimental study)].
Efremova IIa; Il'ina TB; Vishnevskiĭ BI; Vavilin GI
Probl Tuberk; 1977 Sep; (9):61-4. PubMed ID: 411125
[No Abstract] [Full Text] [Related]
22. New experimental regimens for preventive therapy of tuberculosis.
Grosset J
Bull Int Union Tuberc Lung Dis; 1990-1991; 66 Suppl():15-6. PubMed ID: 1983742
[No Abstract] [Full Text] [Related]
23. [Antifibrotic action of sodium succinate in experimental tuberculosis].
Suslov EI; Maliuk VI; Korzhov VI; Gunzburg TS
Probl Tuberk; 1980 Feb; (2):57-9. PubMed ID: 7375465
[No Abstract] [Full Text] [Related]
24. [Experimental substantiation of immunomodulating therapy with sodium nucleinate in tuberculosis].
Cernuşenko EF; Ciumak AA
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(2):143-50. PubMed ID: 6093221
[No Abstract] [Full Text] [Related]
25. [Chemotherapy of tuberculosis. I - Basic principles].
Rosemberg J
AMB Rev Assoc Med Bras; 1983; 29(5-6):90-4. PubMed ID: 6419297
[No Abstract] [Full Text] [Related]
26. [Correction of immunologic deficiency in experimental tuberculosis and chronic effect of pesticides].
Arifkhanova SI; Vakhidova GA
Probl Tuberk; 1991; (5):61-4. PubMed ID: 1924247
[TBL] [Abstract][Full Text] [Related]
27. Delamanid Kills Dormant Mycobacteria
Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
[TBL] [Abstract][Full Text] [Related]
28. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
Grumbach F; Canetti G; Le Lirzin M
Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
[No Abstract] [Full Text] [Related]
29. Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.
Lenaerts AJ; Hoff D; Aly S; Ehlers S; Andries K; Cantarero L; Orme IM; Basaraba RJ
Antimicrob Agents Chemother; 2007 Sep; 51(9):3338-45. PubMed ID: 17517834
[TBL] [Abstract][Full Text] [Related]
30. [Correction of the toxic effect of isoniazid preparations].
Maliuk VI; Sokirko TA
Probl Tuberk; 1987; (8):64-6. PubMed ID: 3684995
[No Abstract] [Full Text] [Related]
31. Experimental investigations of bacteriological mechanisms in short course chemotherapy.
Dickinson JM; Mitchison DA
Bull Int Union Tuberc; 1976; 51(1):79-86. PubMed ID: 829484
[No Abstract] [Full Text] [Related]
32. The importance of decalcification in the treatment of tuberculosis. 3. The influence of decalcification of the course of experimental tuberculosis in guinea pigs infected with tubercle bacilli of low degree resistance to izoniazid.
Garapich M; Jelonek A; Kulig A
Acta Med Pol; 1967; 8(3):313-8. PubMed ID: 4964868
[No Abstract] [Full Text] [Related]
33. [Rifomycin in treatment of tuberculosis with polyresistant mycobacteria: clinical and laboratory observations].
Daddi G; Lucchesi M
Acta Tuberc Pneumol Belg; 1969; 60(3):442-9. PubMed ID: 4984423
[No Abstract] [Full Text] [Related]
34. Considering the role of four months of rifampin in the treatment of latent tuberculosis infection.
Reichman LB; Lardizabal A; Hayden CH
Am J Respir Crit Care Med; 2004 Oct; 170(8):832-5. PubMed ID: 15297274
[No Abstract] [Full Text] [Related]
35. [Serological and pathomorphological aspects of the autoimmunization process in experimental tuberculosis in guinea pigs exposed to fractionated gamma-irradition and treated with isoniazid].
Vulchanov Vkh ; Vasilev VN; Kekhaiov IR
Izv Mikrobiol Inst (Sofiia); 1972; 23():101-9. PubMed ID: 4197600
[No Abstract] [Full Text] [Related]
36. Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs.
Nitti V
Antibiot Chemother; 1970; 16():444-70. PubMed ID: 5002308
[No Abstract] [Full Text] [Related]
37. Rationale for chemotherapy of tuberculosis and current recommendations.
Kumar L
Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
[No Abstract] [Full Text] [Related]
38. [Immunomodulating action of levamisole in influenzal infection in mice].
Volgarev AP; Poliak RIa
Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):88-91. PubMed ID: 6485672
[TBL] [Abstract][Full Text] [Related]
39. Bacterial Factors That Predict Relapse after Tuberculosis Therapy.
Colangeli R; Jedrey H; Kim S; Connell R; Ma S; Chippada Venkata UD; Chakravorty S; Gupta A; Sizemore EE; Diem L; Sherman DR; Okwera A; Dietze R; Boom WH; Johnson JL; Mac Kenzie WR; Alland D;
N Engl J Med; 2018 Aug; 379(9):823-833. PubMed ID: 30157391
[TBL] [Abstract][Full Text] [Related]
40. Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.
Dickinson JM; Mitchison DA
Tubercle; 1970 Mar; 51(1):82-94. PubMed ID: 4992976
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
